SEC 13F Intelligence

Trails Edge Capital Partners, LP / NRIX

Trails Edge Capital Partners, LP’s Nurix Therapeutics Inc Position

Does Trails Edge Capital Partners, LP own Nurix Therapeutics Inc (NRIX)? Yes1.74M shares worth $27M (+6.19% of its 13F portfolio) as of Q1 2026.

Position Value
$27M
Q1 2026
Shares
1.74M
% of Portfolio
+6.19%
Quarters Held
2
currently held

Position History NRIX

Reported value by quarter
Q4 ’25: $33MQ4 ’25Q1 ’26: $27MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.74M$27M+6.19%
Q4 20251.74M$33M+8.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of NRIX.